Propel testing excellence with Mayo Clinic quality
Mayo Clinic Laboratories is a one-stop laboratory solution, offering commercial laboratories a vast testing menu, unparalleled customer service, and optimized processes. We work collaboratively with partners to assess their needs, providing the testing they need to expand into new areas and meet their business goals.
As the reference lab for Mayo Clinic, we’ve developed robust logistics and testing protocols applied uniformly for all specimens received, no matter their geographic origin. Whether you send us one test order or thousands, each sample receives the same treatment and level of care, ensuring superior results that help our partners better serve their clients.
“Our clients want personal experiences. They want someone to answer the phone. They want someone to provide answers when they're looking for results of a sample sent a couple days ago. and we deliver those answers.”
Angie Reese-Davis, director of operations, logistics, and specimen services, Mayo Clinic Laboratories
Our difference
News and updates
The latest
In this video, Dr. Vijay Ramanan shares perspectives on rational approaches to testing in the cognitive neurology, mild cognitive impairment, and dementia settings.
In this episode of Lab Medicine Rounds, as we head into the holiday season, Justin Kreuter, M.D., and Andres Jaramillo, Ph.D., Associate Professor of Laboratory Medicine and Pathology at Mayo Clinic and director of the Histocompatibility Laboratory at Mayo Clinic’s Arizona campus, discuss the ultimate gift of organ transplantation.
This week on "Answers From the Lab," William Morice II, M.D., Ph.D., chair of the Department of Laboratory Medicine and Pathology at Mayo Clinic and president of Mayo Clinic Laboratories, joins the "Answers From the Lab" podcast for his weekly leadership update with Bobbi Pritt, M.D. In this episode, Dr. Morice and Dr. Pritt review steps we can take to keep ourselves and the people around us safe as we celebrate the holidays together.
Recipient of a young investigator award from the American Association of Clinical Chemistry, Dr. Maria Alice Willrich’s work has been crucial in advancing therapeutic drug monitoring to improve outcomes for patients with inflammatory bowel disease.
With the omicron variant grabbing headlines around the world, media outlets have turned to experts like Dr. Binnicker to help clarify the effect this new variant could have and what it might mean for the COVID-19 pandemic.
This week’s research roundup features: Renal Neoplasia in Polycystic Kidney Disease: An assessment of Tuberous Sclerosis complex-associated Renal Neoplasia and PKD1/TSC2 contiguous gene deletion syndrome.
Topic's Include: Mayo Clinic scientist explains genome sequencing of SARS-CoV-2, taking a closer look at the omicron and delta variants, and testing for COVID-19 at home.
Due to the Christmas and New Year's holiday's (recognized on Saturday, December 25th, and Saturday, January 1st ), Mayo Clinic Laboratories' specimen pickup and delivery schedules will be altered. To ensure that your specimen vitality and turnaround times are not affected, plan ahead and note:
December 10, 2021 The laboratory industry is breathing a sigh of relief with the passage of S. 610, the Protecting Medicare and American Farmers from Sequester[...]
Today's Highlights Include: Mayo Clinic research on oral pill vaccines, Omicron vs. delta-What we know so far, and how a COVID home test works and when to use one.
This week on "Answers From the Lab," William Morice II, M.D., Ph.D., chair of the Department of Laboratory Medicine and Pathology at Mayo Clinic and president of Mayo Clinic Laboratories, joins the "Answers From the Lab" podcast for his weekly leadership update with Bobbi Pritt, M.D. This week, Dr. Morice and Dr. Pritt step back and look at where the COVID-19 pandemic stands now, and they consider the potential effects that the omicron variant, expanded testing availability, and the upcoming holidays all could have.
This week’s research roundup features: The management of cancer symptoms and treatment-induced side effects with cannabis or cannabinoids.
The quest to create a test pinpointing the source of the rare, testicular cancer-associated illness successfully concluded in the summer of 2021.